https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/prevention-neural-tube-defects-women-taking-additional-supplements/
Prevention of neural tube defects in women taking additional supplements
22 Mar 2016, 2:57 p.m.
BRC-supported researchers Professors Andrew Copp and Nicholas Greene have led research which suggests that women who are at risk of having children with neural tube defects such as spina bifida may be able to reduce this risk by taking inositol (Vitamin B8) as well as folic acid during pregnancy.The study involved 99 women who had previously had a pregnancy affected by a neural tube defect, and who were planning on becoming pregnant within the next year. Half of these women agreed to be randomly assigned to one of two groups; one group were instructed to take 5 mg of Folic acid each day and a placebo, and the second group were instructed to take 5 mg of Folic acid plus 1 mg of Inositol daily. Among the women who chose not be randomised, many decided to take folic acid and inositol in their next pregnancy.
Overall, fifty-seven of the women became pregnant during the study period. Results showed that none of the women taking both inositol and folic acid had pregnancies with a neural tube defect, compared to three of those who took only folic acid.
This research suggests that for those women for whom folic acid supplements are not sufficient to prevent a neural tube defect, taking inositol in addition to folic acid, may provide greater protection. A larger-scale study is now needed in order to in order to confirm the beneficial effects of inositol.
The findings were published in the British Journal of Nutrition, and received media coverage from a number of different sources including the BBC.
NHS eye gene therapy restores Saffie's sight
Saffie has had her sight restored thanks to life-changing eye gene therapy for rare blindness at GOSH
£3M study led by patient voices targets pain in inflammatory arthritis
A new £3 million research programme involving Great Ormond Street Hospital and University College London researchers aims to tackle one of the largest unmet clinical needs in inflammatory arthritis – pain reduction.
GOSH joins European health leaders to shape the future of paediatric data sharing
More than 50 clinicians, data scientists, digital health innovators and industry leaders came together in Barcelona last month to tackle one of the biggest challenges in paediatric healthcare: how to share health data safely across borders to improve care
Engineered tissue offers hope for children born with ‘missing’ food pipe
Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown oesophagus - the food pipe - shown to safely replace a full section of the organ and restore normal function, including swallowing, in